+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Managing the shortage of intravenous immune globulin

Managing the shortage of intravenous immune globulin


Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 046619162

Download citation: RISBibTeXText

PMID: 9988567

Related references

Managing the shortage of intravenous immune globulin. American Journal of Health-System Pharmacy 55(20): 2090-2093, 1998

Distribution plan for immune globulin intravenous during a shortage. American Journal of Health-System Pharmacy 56(15): 1546-1548, 1999

Infections and antibiotic therapy during the intravenous immune globulin shortage. Journal of Investigative Medicine 47(2): 107A, 1999

Intravenous immune globulin shortage: experience at a large children's hospital. Pediatrics 102(3 Pt 1): 645-647, 1998

Impact of criterion-based guidelines on utilization of intravenous immune globulin during a critical shortage. Pharmacotherapy 20(3): 364, 2000

Intravenous immune globulin versus intravenous anti-D immune globulin for the treatment of acute immune thrombocytopenic purpura. Indian Journal of Pediatrics 75(12): 1231-1235, 2008

The cost of treating immune thrombocytopenic purpura using intravenous Rh immune globulin versus intravenous immune globulin. American Journal of Hematology 63(3): 156-158, 2000

RH-o immune globulin intravenous in patients with ITP and history of prior treatment with intravenous immune globulin and/or corticosteroids. Blood 84(10 Suppl. 1): 187A, 1994

Comparison of intravenous immune globulin and high dose anti-D immune globulin as initial therapy for childhood immune thrombocytopenic purpura. British Journal of Haematology 149(1): 79-83, 2010

Single dose of anti-D immune globulin at 75 microg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children. Journal of Pediatrics 148(4): 489-494, 2006

A preparation of modified immune serum globulin (human) suitable for intravenous administration. Further characterization and comparison with pepsin-treated intravenous gamma globulin. American Journal of Medicine 76(3a): 33-39, 1984

Undegraded -globulin for intravenous therapy. A new preparation of immune serum globulin for intravenous administration. Vox Sanguinis 20(5): 469-478, 1971

Prophylactic intravenous administration of standard immune globulin as compared with core-lipopolysaccharide immune globulin in patients at high risk of postsurgical infection. New England Journal of Medicine 327(4): 234-240, 1992

Intravenous Anti-D Plus Prednisone Versus Intravenous Immune Globulin for the Initial Management of Childhood Immune Thrombocytopenic Purpura. Blood 100(11): Abstract No. 3788, 2002

High-dose intravenous immune globulin therapy for idiopathic thrombocytopenic purpura-efficacy and safety related of anti-red blood cell antibody levels contained in immune globulin products. Japanese Archives of Internal Medicine 40(7): 195-208, 1993